LEXETTE

This brand name is authorized in United States

Active ingredients

The drug LEXETTE contains one active pharmaceutical ingredient (API):

1 Ulobetasol UNII 91A0K1TY3Z - HALOBETASOL PROPIONATE
Ulobetasol is a corticosteroid used for for the topical treatment of plaque psoriasis. Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in plaque psoriasis is unknown. Read about Ulobetasol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LEXETTE Topical foam	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 51862-604

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.